Scribe Therapeutics IPO

Scribe Therapeutics focuses on creating therapies that permanently treat the underlying cause of disease.

Register for Details

For more details on financing and valuation for Scribe Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Scribe Therapeutics

Forge green plus iconForge green minus icon

What is Scribe Therapeutics's IPO price?

The IPO price for Scribe Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Scribe Therapeutics?

Scribe Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Scribe Therapeutics shares pre-IPO?

If you own Scribe Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Scribe Therapeutics a publicly traded company?

Scribe Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Scribe Therapeutics's funding to date?

Scribe Therapeutics has raised $121.16MM to date.
Forge green plus iconForge green minus icon

When was Scribe Therapeutics founded?

Scribe Therapeutics was founded in 2017.

Scribe Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
3/31/2021 Series B $100.45MM raised $XXX.XX $XXX.XX
10/6/2020 Series A $20MM raised $XXX.XX $XXX.XX
6/30/2017 Series A-1 and A-2 $705.4K raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.